ES2135148T3 - Compuestos de imidazolidin-2,4-diona substituidos como inmunomoduladores. - Google Patents
Compuestos de imidazolidin-2,4-diona substituidos como inmunomoduladores.Info
- Publication number
- ES2135148T3 ES2135148T3 ES96116069T ES96116069T ES2135148T3 ES 2135148 T3 ES2135148 T3 ES 2135148T3 ES 96116069 T ES96116069 T ES 96116069T ES 96116069 T ES96116069 T ES 96116069T ES 2135148 T3 ES2135148 T3 ES 2135148T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- sup
- diona
- imidazolidin
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE DESCRIBEN COMPUESTOS SUSTITUIDOS DE IMIDAZOLIDIN-2,4-DIONA, PROCEDIMIENTO PARA SU OBTENCION Y LA UTILIZACION DE ESTOS COMPUESTOS COMO MEDICAMENTOS, DE FORMULA I EN DONDE R{SUP,1} ES ALQUILO DE C{SUB,1-6} O CICLOALQUILO DE C{SUB,3-6}, R{SUP,2} ES ALQUILO DE C{SUB,1-6}, FENILO, -(CH{SUB,2}){SUB,1-3}FENILO O -(CH{SUB,2}){SUB,1-4}-COOR{SUP,5} O R{SUP,1} Y R{SUP,2} SON JUNTOS -(CH{SUB,2}){SUB,4-6}-, (CH{SUB,2}){SUB,2}-O-(CH{SUB,2}){SUB,2}- O R{SUP,3} ES H, ALQUILO DE C{SUB,1-5} O -(CH{SUB,2}){SUB,1-4}COOR{SUP,5}, R{SUP,4} ES UN COMPUESTO HETEROAROMATICO DEL GRUPO CON LAS FORMULAS R{SUP,5} ES ALQUILO DE C{SUB,1-3}, R{SUP,6} ES H, ALQUILO DE C{SUB,1-4}, FENILO O BENCILO, R{SUP,7} ES H, ALQUILO DE C{SUB,1-4} O TRIFLUOROMETILO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19540027A DE19540027A1 (de) | 1995-10-27 | 1995-10-27 | Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2135148T3 true ES2135148T3 (es) | 1999-10-16 |
Family
ID=7775931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96116069T Expired - Lifetime ES2135148T3 (es) | 1995-10-27 | 1996-10-08 | Compuestos de imidazolidin-2,4-diona substituidos como inmunomoduladores. |
Country Status (23)
Country | Link |
---|---|
US (1) | US6004963A (es) |
EP (1) | EP0770613B1 (es) |
JP (1) | JPH09188677A (es) |
KR (1) | KR100445539B1 (es) |
CN (1) | CN1097050C (es) |
AR (1) | AR004517A1 (es) |
AT (1) | ATE181072T1 (es) |
AU (1) | AU707751B2 (es) |
CA (1) | CA2188908A1 (es) |
CO (1) | CO4750655A1 (es) |
DE (2) | DE19540027A1 (es) |
DK (1) | DK0770613T3 (es) |
ES (1) | ES2135148T3 (es) |
GR (1) | GR3030558T3 (es) |
HK (1) | HK1010367A1 (es) |
HU (1) | HU222120B1 (es) |
IL (1) | IL119488A (es) |
MX (1) | MX9605023A (es) |
PE (1) | PE20011055A1 (es) |
PL (1) | PL184446B1 (es) |
RU (1) | RU2163603C2 (es) |
SI (1) | SI0770613T1 (es) |
ZA (1) | ZA968956B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19732928C2 (de) * | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
DE19917961A1 (de) | 1999-04-21 | 2000-10-26 | Degussa | Verfahren zur Herstellung von Aminosäurederivaten |
WO2001007048A1 (en) * | 1999-07-21 | 2001-02-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
WO2001092253A2 (en) | 2000-05-31 | 2001-12-06 | Tanabe Seiyaku Co., Ltd. | Inhibitors of alpha l beta 2 mediated cell adhesion |
US7354933B2 (en) | 2003-01-31 | 2008-04-08 | Aventis Pharma Sa | Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
FR2850652B1 (fr) * | 2003-01-31 | 2008-05-30 | Aventis Pharma Sa | Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
WO2005090316A1 (en) * | 2004-03-12 | 2005-09-29 | Wyeth | HYDANTOINS HAVING RNase MODULATORY ACTIVITY |
EP1621535A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
EP1621539A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
EP1621536A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
FR2896504B1 (fr) * | 2006-01-23 | 2012-07-13 | Aventis Pharma Sa | Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
FR2896503B1 (fr) * | 2006-01-23 | 2012-07-13 | Aventis Pharma Sa | Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
AU2012241184B2 (en) * | 2006-03-27 | 2016-01-07 | The Regents Of The University Of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
AU2013205325B2 (en) * | 2006-03-27 | 2016-03-24 | The Regents Of The University Of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
EP2656842B1 (en) | 2006-03-27 | 2016-08-10 | The Regents of The University of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
AU2016201061B2 (en) * | 2006-03-27 | 2017-03-02 | The Regents Of The University Of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
EP3020706A1 (en) | 2006-03-29 | 2016-05-18 | The Regents Of The University Of California | Diarylthiohydantoin compounds useful for the treatment of a hyperproliferative disorder |
US7649007B2 (en) * | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
US7652018B2 (en) * | 2006-08-15 | 2010-01-26 | Wyeth Llc | Imidazolidin-2-one derivatives useful as PR modulators |
US7538107B2 (en) | 2006-08-15 | 2009-05-26 | Wyeth | Oxazinan-2-one derivatives useful as PR modulators |
TW200815428A (en) | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
AU2007292992B2 (en) * | 2006-09-08 | 2013-01-10 | Actelion Pharmaceuticals Ltd | Pyridin-3-yl derivatives as immunomodulating agents |
CA2966280A1 (en) | 2007-10-26 | 2009-04-30 | The Regents Of The University Of California | Diarylhydantoin compounds |
MX2010014572A (es) * | 2008-06-27 | 2011-03-24 | Novartis Ag | Compuestos organicos. |
SG10201402250TA (en) | 2009-05-12 | 2014-07-30 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
PT3124481T (pt) | 2010-02-16 | 2018-06-18 | Aragon Pharmaceuticals Inc | Moduladores do receptor de androgénios e suas utilizações |
EA030128B1 (ru) | 2012-09-26 | 2018-06-29 | Арагон Фармасьютикалз, Инк. | Способ лечения неметастатического кастрационно-резистентного рака простаты |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
US10702508B2 (en) | 2017-10-16 | 2020-07-07 | Aragon Pharmaceuticals, Inc. | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0091596B1 (de) * | 1982-04-08 | 1991-09-11 | Shell Internationale Researchmaatschappij B.V. | Neue Hydantoine, ihre Herstellung und Verwendung |
US4746669A (en) * | 1985-12-23 | 1988-05-24 | Merck & Co., Inc. | Substituted thiazoles as immunoregulants |
JPH02101065A (ja) * | 1988-10-06 | 1990-04-12 | Tanabe Seiyaku Co Ltd | イミダゾリン誘導体及びその製法 |
AU9030691A (en) * | 1990-11-06 | 1992-05-26 | Smithkline Beecham Corporation | Imidazolidinone compounds |
IL110296A (en) * | 1993-07-16 | 1999-12-31 | Smithkline Beecham Corp | Imidazole compounds process for their preparation and pharmaceutical compositions containing them |
US7466669B2 (en) * | 2003-11-14 | 2008-12-16 | Telefonaktiebolaget Lm Ericsson (Publ) | Reverse link scheduler for CDMA networks |
-
1995
- 1995-10-27 DE DE19540027A patent/DE19540027A1/de not_active Withdrawn
-
1996
- 1996-09-26 PE PE1996000688A patent/PE20011055A1/es not_active Application Discontinuation
- 1996-10-04 CO CO96052910A patent/CO4750655A1/es unknown
- 1996-10-08 EP EP96116069A patent/EP0770613B1/de not_active Expired - Lifetime
- 1996-10-08 DE DE59602155T patent/DE59602155D1/de not_active Expired - Fee Related
- 1996-10-08 DK DK96116069T patent/DK0770613T3/da active
- 1996-10-08 ES ES96116069T patent/ES2135148T3/es not_active Expired - Lifetime
- 1996-10-08 SI SI9630066T patent/SI0770613T1/xx not_active IP Right Cessation
- 1996-10-08 AT AT96116069T patent/ATE181072T1/de not_active IP Right Cessation
- 1996-10-14 AU AU68181/96A patent/AU707751B2/en not_active Ceased
- 1996-10-16 AR ARP960104778A patent/AR004517A1/es unknown
- 1996-10-22 MX MX9605023A patent/MX9605023A/es unknown
- 1996-10-24 JP JP8282701A patent/JPH09188677A/ja active Pending
- 1996-10-24 HU HU9602932A patent/HU222120B1/hu not_active IP Right Cessation
- 1996-10-24 ZA ZA968956A patent/ZA968956B/xx unknown
- 1996-10-25 US US08/738,232 patent/US6004963A/en not_active Expired - Fee Related
- 1996-10-25 KR KR1019960048441A patent/KR100445539B1/ko not_active IP Right Cessation
- 1996-10-25 IL IL11948896A patent/IL119488A/xx not_active IP Right Cessation
- 1996-10-25 PL PL96316706A patent/PL184446B1/pl not_active IP Right Cessation
- 1996-10-25 CA CA002188908A patent/CA2188908A1/en not_active Abandoned
- 1996-10-25 RU RU96121181/04A patent/RU2163603C2/ru not_active IP Right Cessation
- 1996-10-26 CN CN96121960A patent/CN1097050C/zh not_active Expired - Fee Related
-
1998
- 1998-09-25 HK HK98110963A patent/HK1010367A1/xx not_active IP Right Cessation
-
1999
- 1999-06-17 GR GR990401639T patent/GR3030558T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL184446B1 (pl) | 2002-10-31 |
KR970021076A (ko) | 1997-05-28 |
MX9605023A (es) | 1997-06-28 |
HUP9602932A3 (en) | 1998-08-28 |
IL119488A0 (en) | 1997-01-10 |
DE59602155D1 (de) | 1999-07-15 |
EP0770613B1 (de) | 1999-06-09 |
SI0770613T1 (en) | 1999-10-31 |
EP0770613A1 (de) | 1997-05-02 |
CA2188908A1 (en) | 1997-04-28 |
CN1152573A (zh) | 1997-06-25 |
DK0770613T3 (da) | 1999-12-13 |
HU9602932D0 (en) | 1996-12-30 |
PE20011055A1 (es) | 2001-12-29 |
CO4750655A1 (es) | 1999-03-31 |
PL316706A1 (en) | 1997-04-28 |
ZA968956B (en) | 1997-05-29 |
HU222120B1 (hu) | 2003-04-28 |
CN1097050C (zh) | 2002-12-25 |
JPH09188677A (ja) | 1997-07-22 |
HUP9602932A2 (hu) | 1998-07-28 |
IL119488A (en) | 2001-01-11 |
RU2163603C2 (ru) | 2001-02-27 |
AR004517A1 (es) | 1998-12-16 |
ATE181072T1 (de) | 1999-06-15 |
HK1010367A1 (en) | 1999-06-17 |
DE19540027A1 (de) | 1997-04-30 |
US6004963A (en) | 1999-12-21 |
KR100445539B1 (ko) | 2004-12-30 |
AU707751B2 (en) | 1999-07-22 |
GR3030558T3 (en) | 1999-10-29 |
AU6818196A (en) | 1997-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2135148T3 (es) | Compuestos de imidazolidin-2,4-diona substituidos como inmunomoduladores. | |
MX9304996A (es) | Heterociclos no-aromaticos que contienen bencilamino nitrogeno substituido. | |
DK0946507T3 (da) | Substituerede pyrrolylforbindelser til behandling af inflammation | |
YU48995B (sh) | Derivati hinuklidina | |
ES2150808T3 (es) | Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico. | |
AR241531A1 (es) | Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables. | |
DE69911935D1 (de) | Granulatimide-derivate zur behandlung von krebs | |
ES551337A0 (es) | Metodo de preparar derivados de b-carbolin-3-oxadiazolilo | |
ES2144885T3 (es) | Empleo como un fungicida de derivados de acido beta-amino-propionico. | |
YU33490A (sh) | Antivirusna tetrahidroimidazo (1,4)benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje | |
ES2125161B1 (es) | Nuevos derivados de 2-(3h)-oxazolona. | |
EA200000082A1 (ru) | Производные циклопентенона | |
ES2054502T3 (es) | Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion. | |
ES553412A0 (es) | Un procedimiento para la produccion de derivados de benzoilurea | |
DE3787790T2 (de) | Indenderivate und Verfahren. | |
GR1000887B (el) | Νεα παραγωγα σπιροφουρανης. | |
PT945430E (pt) | N-fenilacetoacetamidas e processo para a sua producao | |
EA199900836A1 (ru) | Противосудорожные производные изохинолилбензамида | |
ES2140552T3 (es) | Derivados indol como inhibidores de la 5-alfa-reductasa-1. | |
ATE136307T1 (de) | Trazodone alkyl derivate mit zns wirkung | |
PT89029A (pt) | Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina | |
FI934468A (fi) | Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytes mellanprodukter | |
ITMI920018A0 (it) | Derivati dell'acido 2,4-diammino-1,3,5-triazinil-6-fosforico | |
ES2150564T3 (es) | Proceso para la preparacion de derivados de 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftaleno. | |
ES529560A0 (es) | Procedimiento para la produccion de n-pirrolilfenil-n'-benzoilureas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 770613 Country of ref document: ES |